These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 16622461)
41. Serum Lactate Dehydrogenase Can Be Used as a Factor for Re-Evaluating First-Relapsed Multiple Myeloma. Liu Y; Wen L; Chen H; Chen Y; Duan W; Kang Y; Ma L; Huang X; Lu J Acta Haematol; 2020; 143(6):559-566. PubMed ID: 32610311 [TBL] [Abstract][Full Text] [Related]
42. The diagnostic performance of current tumour markers in surveillance for recurrent testicular cancer: A diagnostic test accuracy systematic review. Nicholson BD; Jones NR; Protheroe A; Joseph J; Roberts NW; Van den Bruel A; Fanshawe TR Cancer Epidemiol; 2019 Apr; 59():15-21. PubMed ID: 30658216 [TBL] [Abstract][Full Text] [Related]
43. American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors. Gilligan TD; Seidenfeld J; Basch EM; Einhorn LH; Fancher T; Smith DC; Stephenson AJ; Vaughn DJ; Cosby R; Hayes DF; J Clin Oncol; 2010 Jul; 28(20):3388-404. PubMed ID: 20530278 [TBL] [Abstract][Full Text] [Related]
44. Absence of sperm-specific lactate dehydrogenase-x in patients with testis cancer. Vogelzang NJ; Lange PH; Goldberg E Oncodev Biol Med; 1982; 3(4):269-72. PubMed ID: 6291005 [TBL] [Abstract][Full Text] [Related]
45. Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review. Chakiryan NH; Dahmen A; Cucchiara V; Briganti A; Montorsi F; Salonia A; Spiess PE; Necchi A J Urol; 2021 Jun; 205(6):1569-1576. PubMed ID: 33617328 [TBL] [Abstract][Full Text] [Related]
46. Laboratory markers and germ cell tumors. von Eyben FE Crit Rev Clin Lab Sci; 2003 Aug; 40(4):377-427. PubMed ID: 14582602 [TBL] [Abstract][Full Text] [Related]
47. Prognostic factors in seminomas with special respect to HCG: results of a prospective multicenter study. Seminoma Study Group. Weissbach L; Bussar-Maatz R; Löhrs U; Schubert GE; Mann K; Hartmann M; Dieckmann KP; Fassbinder J Eur Urol; 1999 Dec; 36(6):601-8. PubMed ID: 10559615 [TBL] [Abstract][Full Text] [Related]
48. miR-371a-3p, miR-373-3p and miR-367-3p as Serum Biomarkers in Metastatic Testicular Germ Cell Cancers Before, During and After Chemotherapy. Rosas Plaza X; van Agthoven T; Meijer C; van Vugt MATM; de Jong S; Gietema JA; Looijenga LHJ Cells; 2019 Oct; 8(10):. PubMed ID: 31597402 [TBL] [Abstract][Full Text] [Related]
49. Early detection of relapse after treatment for metastatic germ cell tumour of the testis: an exercise in medical audit. Rathmell AJ; Brand IR; Carey BM; Jones WG Clin Oncol (R Coll Radiol); 1993; 5(1):34-8. PubMed ID: 7678749 [TBL] [Abstract][Full Text] [Related]
50. Neuron-specific enolase--a serum tumour marker in seminoma? Fosså SD; Klepp O; Paus E Br J Cancer; 1992 Feb; 65(2):297-9. PubMed ID: 1739633 [TBL] [Abstract][Full Text] [Related]
51. Value of surveillance studies for patients with stage I to II diffuse large B-cell lymphoma in the rituximab era. Hiniker SM; Pollom EL; Khodadoust MS; Kozak MM; Xu G; Quon A; Advani RH; Hoppe RT Int J Radiat Oncol Biol Phys; 2015 May; 92(1):99-106. PubMed ID: 25863757 [TBL] [Abstract][Full Text] [Related]
52. A systematic review of lactate dehydrogenase isoenzyme 1 and germ cell tumors. von Eyben FE Clin Biochem; 2001 Sep; 34(6):441-54. PubMed ID: 11676973 [TBL] [Abstract][Full Text] [Related]
53. Surveillance policy for Japanese patients with stage I testicular germ cell cancer in the multi-detector computed tomography era. Yuasa T; Inoshita N; Tanaka H; Urakami S; Yamamoto S; Fujii Y; Masuda H; Fukui I; Ishikawa Y; Yonese J Int J Clin Oncol; 2015 Dec; 20(6):1198-202. PubMed ID: 25893862 [TBL] [Abstract][Full Text] [Related]
54. Compliance and outcome of patients with stage 1 non-seminomatous germ cell tumors (NSGCT) managed with surveillance programs in seven Canadian centres. Ernst DS; Brasher P; Venner PM; Czaykowski P; Moore MJ; Reyno L; Winquist E; Segal R; Hao D Can J Urol; 2005 Apr; 12(2):2575-80. PubMed ID: 15877938 [TBL] [Abstract][Full Text] [Related]
55. The value of tumor markers in testicular seminomas. Results of a prospective multicenter study. Weissbach L; Bussar-Maatz R; Mann K Eur Urol; 1997; 32(1):16-22. PubMed ID: 9266226 [TBL] [Abstract][Full Text] [Related]
56. Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours. Dieckmann KP; Radtke A; Spiekermann M; Balks T; Matthies C; Becker P; Ruf C; Oing C; Oechsle K; Bokemeyer C; Hammel J; Melchior S; Wosniok W; Belge G Eur Urol; 2017 Feb; 71(2):213-220. PubMed ID: 27495845 [TBL] [Abstract][Full Text] [Related]
57. Changes in lactate dehydrogenase isoenzymes associated with relapse of childhood acute lymphocytic leukemia. Kovesi TA; Hsu E Pediatr Hematol Oncol; 1994; 11(5):527-33. PubMed ID: 7826848 [TBL] [Abstract][Full Text] [Related]